AI in Deep Brain Stimulation for Movement Disorders: A Review
This systematic review and technology readiness assessment examines the integration of artificial intelligence (AI) into deep brain stimulation (DBS) for treating movement disorders. The study delves into how AI algorithms are being developed and applied to enhance the efficacy and precision of DBS therapy. It highlights the potential of AI to personalize treatment parameters, predict patient responses, and optimize stimulation delivery in real-time. The review also assesses the current stage of technological development and readiness for widespread clinical adoption of AI-powered DBS systems. Researchers explored various AI techniques, including machine learning and deep learning, and their specific applications in modulating neural circuits for conditions such as Parkinson's disease, essential tremor, and dystonia. The findings aim to provide a comprehensive overview of the state-of-the-art and identify future research directions and clinical implementation challenges. The assessment considers factors like data availability, algorithm validation, hardware integration, and regulatory pathways necessary for translating AI innovations from research labs to patient care. Ultimately, the review seeks to guide clinicians, researchers, and developers in leveraging AI to improve outcomes for individuals suffering from debilitating movement disorders.
AI's integration into deep brain stimulation for movement disorders represents a significant technological advancement, promising more personalized and adaptive therapeutic interventions. The systematic review and technology readiness assessment highlight the potential for AI to optimize stimulation parameters, thereby improving patient outcomes and potentially reducing side effects. However, the transition from research to clinical practice necessitates careful consideration of data privacy, algorithmic transparency, and robust validation processes to ensure patient safety and trust. As AI capabilities mature, the focus will likely shift towards developing closed-loop systems that can autonomously adjust stimulation based on real-time physiological feedback, further enhancing treatment efficacy. This evolution underscores the importance of interdisciplinary collaboration between AI experts, neuroscientists, clinicians, and regulatory bodies to navigate the complexities of implementing these advanced technologies responsibly and equitably.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.